News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on OncoSil Medical.
RELATED STOCKHEAD STORIES
News
Closing Bell: Welcome to the palladium and uranium show
Health & Biotech
Who’s carrying on the Cochlear legacy? The ASX med device stocks that could soar from tailwinds
Health & Biotech
Check Up: Biotechs are going through a rough patch, but recent ASX IPOs haven’t flopped too badly
News
Rise and Shine: Everything you need to know before the ASX opens
News
Closing Bell: Small caps go full Maximus, unleash gains in face of rising broad-based fears
News
ASX Small Cap Lunch Wrap: Who’s standing to attention today?
News
ASX Health Stocks: OncoSil rips higher as its device goes live in Spain
News
Top 10 at 10: The ASX stocks blowing your socks off in early trade
Health & Biotech
ASX Health Stocks: OncoSil and PainChek set to embark on overseas expansion
Health & Biotech
ASX Health Stocks: OncoSil up 15pc on German device funding; Starpharma expands to Middle East
News
Top 10 at 10: The ASX stocks looking succulent and stale this morn
News
ASX Lunch Small Cap Wrap: Who’s scrambling to the Christmas finish line this morning?
Health & Biotech
ASX Health Stocks: OncoSil and Neuroscientific Biopharma release positive clinical results
News
10 at 10: These ASX stocks are gifts that keep on giving this morning
News
Last Orders: Tech stocks lost nearly 2 per cent; but the rest of the ASX in the green
News
Last Orders: What you might have missed on the ASX today
News